PMID int64 27.8M 36.2M | Title/Abstract stringlengths 7 10.7k | MeshTerms stringlengths 7 104 | SemanticTypes stringlengths 4 84 |
|---|---|---|---|
34,670,082 | sc otf catalyz iodocyclizationritt type amid n alkoxypropiolamid synthet strategi isoxazol h one sc otf catalyz iodocyclizationritt type amid n alkoxypropiolamid synthesi iodoisoxazol h one bear amid group develop domino protocol allow construct valuabl heterocycl isoxazol h one well introduct two function group reaction broad substrat scope carri larg scale control experi suggest sc otf act dual activ iodocycl amid step addit n alkoxi group substrat suppress side reaction | D000577;D000737 | T109 |
34,670,081 | robot assist spidermass vivo real time topographi mass spectrometri imag mass spectrometri imag msi shown bring invalu inform biolog clinic applic howev convent msi general perform ex vivo tissu section develop novel ms base method vivo mass spectrometri imag coupl spidermass technolog provid vivo minim invas analysi robot arm high accuraci demonstr imag acquir surfac move laser probe surfac equip robot arm sensor also abl get topographi imag sampl surfac molecular distribut plot back molecular data direct topograph imag without need imag fusion shown first time topograph ms base whole bodi imag mous enabl fast vivo msi bridg topographi pave way surgic applic excis margin | D012371 | T090 |
34,670,079 | nitrogen contain aromat radic anion perform multipl proton electron transfer near simultan multipli proton cation gas phase ionion reaction singl charg radic reagent anion multipli charg cation precursor primarili result either proton electron transfer ionion reaction extens studi bioanalysi mani reagent anion test report nitrogen contain aromat radic anion test abil conduct proton electron transfer reaction ubiquitin h precursor singl charg anion biquinolin found undergo charg invers singl proton cation via near simultan proton electron transfer reactant bound singl ionion reaction complex although focus paper biquinolin three nitrogen contain aromat compound test produc similar result | D009584;D011522 | T196;T123 |
34,670,077 | long term sustain drug deliveri via print mask develop heparin load interlay vascular tissu engin applic current approach small diamet vascular graft coronari arteri bypass surgeri fail address physiolog variat along graft contribut thrombus format ultim graft failur present innov interlay drug deliveri system util sustain deliveri heparin graft high degre tempor spatial control heparin load gelatin methacryl gelma interlay sit within biohybrid compos decellular bovin pericardium decm poli propylen fumar ppf uv crosslink control via three dimension print shadow mask mask readili design modul incid light intens graft enabl us control result gelma crosslink properti high heparin load effici obtain gelma independ crosslink achiev sustain heparin releas cours week within biohybrid materi use print mask pattern high dose heparin observ detriment effect endotheli cell function howev expos heparin slower sustain manner consist mask endotheli cell behav similar untreat cell slower releas profil caus signific releas tissu factor pathway inhibitor anticoagul faster releas profil heparin load gelma interlay develop use tool tempor spatial control heparin releas support endotheli function promot antithrombot environ | D016503;D066330;D023822 | T061;T074;T073 |
34,670,076 | c graph tool graphic user interfac dissect conserv hydrogen bond network applic visual rhodopsin dynam hydrogen bond network provid protein structur plastic requir translat signal ligand bind cellular respons transport ion larger solut across membran thus central interest understand protein reaction mechan present c graph effici tool graphic user interfac analyz data set static protein structur independ numer simul identifi conserv vs uniqu hydrogen bond hydrogen bond network static structur may belong protein protein differ sequenc c graph use cluster algorithm identifi site hydrogen bond network water conserv among structur use c graph identifi intern protein water hydrogen bond network common static structur visual rhodopsin adenosin aa g protein coupl receptor gpcrs molecular dynam simul visual rhodopsin indic conserv hydrogen bond network static structur recruit dynam hydrogen bond extend throughout receptor releas work code c graph graphic user interfac | D012243;D014867 | T116;T121;T197;T123 |
34,670,075 | effici isothiocyan modif peptid facilit structur analysi radic direct dissoci radic direct dissoci rdd power techniqu structur character peptid mass spectrometri experi prior analysi radic precursor must typic append facilit generat free radic explor use radic precursor easili attach singl step modifi peptid use click reaction iodophenyl isothiocyan coupl amin function group proceed high yield produc stabl iodophenylthiourea modifi peptid photodissoci yield record nm iodo isom modifi found highest iodo isom near case fragment modifi peptid follow collision activ reveal favor loss tag electron structur calcul use evalu potenti mechan involv hydrogen transfer within thiourea group examin rdd data reveal iodobenzo acid iodophenylthiourea iodotyrosin yield similar fragment pattern given peptid although differ fragment abund note iodophenyl isothiocyan label combin rdd use differenti isomer amino acid within peptid facilit simplifi evalu isom present complex biolog sampl | D007463;D010455 | T116;T121;T109 |
34,670,044 | aqp promot variant water transport outcom periton dialysi variabl ultrafiltr influenc prescript outcom patient kidney failur treat periton dialysi variant aqp gene encod archetyp water channel aquaporin may contribut variabl | D014644;D010530 | T070;T061 |
34,670,034 | induct social pessim reduc pain respons past work found optim reduc person respons pain effect pessim clear therefor gave pessimist forecast particip futur social life measur chang pain respons particular particip told would end alon life | D000067657 | T041 |
34,670,033 | perform diagnost criteria fibromyalgia tertiari care pain rehabilit set diagnost accuraci studi intern classif diseas th revis classifi fibromyalgia primari pain disord soon implement import pain physician abl identifi patient fibromyalgia emphas diagnost criteria propos base self report pain distribut symptom sever studi aim evalu diagnost accuraci diagnost criteria fibromyalgia appli popul patient high impact chronic pain refer pain rehabilit | D059350;D005356 | T047;T184 |
34,670,032 | placent find associ neurodevelopment outcom neonat hypox ischem encephalopathi year singl center experi although neonat moder sever hypox ischem encephalopathi hie receiv therapeut hypothermia th die signific neurolog disabl aim studi analys associ placent patholog neurodevelopment outcom cool neonat hie month age | D002657 | T040;T039 |
34,670,031 | age adapt percentil measur glomerular filtrat healthi individu extrapol live kidney donor year data glomerular filtrat rate gfr origin subject year old complic decis make elder live kidney donor retrospect multi center studi calcul percentil measur gfr mgfr donor year old extrapol donor year old | D016030 | T061 |
34,670,030 | extern qualiti assess serum indic spanish seqc ml program serum indic includ clinic chemistri instrument wide use laboratori assess qualiti sampl instrument report quantit result allow evalu diagnost perform similar way biochem test spanish societi laboratori medicin seqc ml launch month extern qualiti program serum indic use three lyophil materi simultan annual distribut present result first three year program | D007753;D059021 | T057;T093;T073 |
34,670,029 | simultan benzodiazepin ssri initi young peopl anxieti disord object potenti risk benefit combin benzodiazepin bzd select serotonin reuptak inhibitor ssri therapi anxieti disord treatment onset investig often adolesc young adult anxieti disord simultan initi bzd treatment ssri treatment examin whether ssri treatment durat vari simultan bzd initi | D001008;D001569;D004359;D000081206;D017367 | T121;T079;T109;T048;T061 |
34,670,026 | deep brain stimul ventral capsuleventr striatum treatment resist depress decad clinic follow object deep brain stimul dbs emerg therapi treatment resist depress trd shown variabl efficaci report describ long term outcom dbs trd | D061218 | T048 |
34,670,025 | continu magnet seizur therapi treatment resist unipolar bipolar depress object electroconvuls therapi ect high effect treatment resist depress trd may associ advers cognit effect magnet seizur therapi mst promis altern convuls treatment safer cognit profil although emerg evid efficaci mst trd acut treatment publish studi continu mst prevent relaps | D001714;D003865;D061218;D055502;D050781 | T048;T062;T061 |
34,670,024 | efficaci safeti short term combin therapi ticagrelor ppis hra patient acut stemi underw emerg pci combin therapi platelet inhibitor acid suppress agent recommend patient acut st segment elev myocardi infarct stemi underw percutan coronari intervent pci remain pauciti data evalu efficaci safeti combin prospect studi total patient acut stemi underw pci divid four group pantoprazol ticagrelor omeprazol ticagrelor ranitidin ticagrelor ticagrelor risk pci antithrombot efficaci cardiac function main end point evalu compar signific differ found infarct relat arteri perfus index thrombolysi myocardi infarct timi correct timi frame count incid stent thrombosi pci platelet indic platelet count mean platelet volum platelet distribut width platelet activ p selectin glycoprotein iibiiia level platelet aggreg thrombelastographi indic adp adp myocardi necrosi biomark creatin kinas isoenzym mb cardiac troponin level brain natriuret peptid level incid ischem end point event incid tissu organ bleed event among four group incid gastrointestin gi bleed event proton pump inhibitor ppi group signific lower control group wherea h receptor antagonist hra group signific differ control group short term combin therapi ticagrelor ppis hra safe effect patient acut stemi pci addit ppis combin ticagrelor could reduc incid gi bleed event without increas incid ischem event | D062645;D000072657 | T047;T061 |
34,670,022 | implic hiv coinfect plasma exposur rifampicin pyrazinamid ethambutol tuberculosi patient contrast find regard effect hiv pharmacokinet first line anti tubercular drug flatd due lack prospect control clinic studi includ patient tuberculosi tb patient tb live hiv studi aim assess effect hiv coinfect antivir therapi plasma exposur flatd patient tb hiv negat tb hiv group n hiv posit tb hiv group n adult patient tb enrol second month flatd treatment tb hiv patient treatment lamivudin tenofovir zidovudin raltegravir efavirenz serial blood sampl collect h flatd pharmacokinet paramet evalu use noncompartment method tb hiv patient dose normal plasma exposur area curv zero h nauc geometr mean confid interv ci valu steadi state rifampicin pyrazinamid ethambutol ci ci ci ghml respect similar plasma exposur found tb hiv patient geometr mean ci ratio tb hiv tb hiv group suggest signific pharmacokinet interact select antivir flatd likewis hiv coinfect appear effect plasma exposur flatd | D015658;D014376 | T047 |
34,670,021 | incident find uk healthi volunt screen covid vaccin trial safeti novel therapeut vaccin typic assess earli phase clinic trial involv healthi volunt abnorm individu difficult interpret may indic previous unrecogn medic condit frequenc incident find if healthi volunt attend clinic trial screen unclear assess retrospect analyz data healthi volunt screen enrol uk multicent phase iii sever acut respiratori syndrom coronavirus sar cov vaccin trial particip predomin white median age year interquartil rang iqr particip least one detect likelihood identifi evid potenti new blood born virus infect low particip compar identif elev alanin transaminas alt particip larg proport particip describ social habit could impact negat health consum alcohol excess current smoker describ recreat drug use bodi weight ideal rang data demonstr screen prior enrol earli phase clinic trial identifi rang if inform discuss consent process greater clariti need ensur appropri balanc struck earli identif medic problem avoid exclus volunt due spurious physiolog abnorm debat inform role trial physician highlight advis unhealthi social habit | D033162 | T033 |
34,670,019 | microindent techniqu creat local cartilag microfractur articular cartilag multiphas anisotrop heterogen materi although cartilag possess excel mechan biolog properti undergo mechan damag result osteoarthr thus import understand microscal failur behavior cartilag basic scienc clinic context determin cartilag failur behavior mechan provid insight improv treatment strategi delay osteoarthr initi progress also enhanc valu cartilag bioinspir materi fabric investig microscal failur behavior develop protocol initi fractur appli microindent techniqu use well defin tip geometri creat local crack across rang load rate protocol includ extract tissu joint prepar sampl microfractur various aspect experi load profil solvent adjust mimic physiolog patholog condit therebi clarifi phenomena under articular cartilag failur wiley period llc basic protocol harvest dissect joint surfac basic protocol prepar sampl microindent fatigu test basic protocol microfractur use microindent basic protocol crack propag cyclic load | D002358;D015775;D010003 | T047;T046;T024;T037 |
34,670,017 | influenc cypd metabol status ondansetron efficaci pediatr patient undergo hematopoiet stem cell transplant case seri chemotherapi induc nausea vomit cinv common experienc patient receiv antineoplast agent prior hemopoiet stem cell transplant hsct ondansetron ht antagonist metabol cypd antiemet prescrib treat short term cinv patient still experi uncontrol nausea vomit take ondansetron adult cypd ultrarapid metabol um higher risk cinv due rapid ondansetron clearanc similar studi perform pediatr patient perform retrospect chart review pediatr hsct recipi receiv ondansetron cinv prevent cypd genotyp allel duplic detect number emet episod patient collect start chemotherapi day hsct averag age cohort year rang includ three um normal metabol intermedi metabol six poor metabol um popul risk inefficaci describ cours treatment three patient well factor influenc emesi chemotherapi emetogen diagnosi durat ondansetron administr case describ support guidelin recommend non cypd metabol antiemet eg granisetron patient known cypd um pediatr studi larger sampl cypd um need valid find | D000932;D000970;D018380 | T061;T039;T121;T109 |
34,670,016 | good far far good impact refer genom evolutionari infer genom divers past popul histori key consider field conserv evolutionari biolog issu molecular ecolog resourc prasad et al mol ecol resour examin qualiti phylogenet diverg refer genom influenc outcom downstream analys divers demograph histori infer use beluga whale rowi kiwi exampl figur systemat estim heterozygos run homozygos roh demograph histori psmc use refer genom vari qualiti phylogenet diverg target speci show demograph histori analys impact phylogenet distanc although pronounc diverg exceed target speci similar result impli heterozygos estim depend phylogenet distanc method use perform estim roh potenti undetect nonconspecif refer use investig role diverg qualiti refer genom highlight impact potenti bias generat genom select downstream analys provid possibl altern cross speci scaffold instanc conspecif refer genom avail | D005075;D016678 | T028;T045 |
34,670,014 | metallurg characteris torsion resist blue thermomechan treat nickel titanium instrument simul ex vivo retreat procedur compar use unus reciproc blue reciproc retreat instrument use mesiobucc canal maxillari molar curvatur torsion resist test unus instrument subject xrd dsc microhard test student anova tukey test perform level torsion strength use reciproc blue signific differ unus one p torsion strength reciproc decreas signific p dsc xrd indic reciproc blue exhibit promin transform peak correspond austenit r phase microhard reciproc signific higher p second reus reciproc blue retreat could consid safe term torsion strength blue treatment also decreas surfac microhard instrument chang phase composit increas r phase | D003762;D018915 | T074;T061 |
34,670,012 | effect eicosapentaeno acid serum level selenoprotein p organ specif insulin sensit human dyslipidemia type diabet selenoprotein p sep encod selenop human hepatokin caus insulin resist liver skelet muscl found polyunsatur fatti acid eicosapentaeno acid epa downregul selenop express inactiv srebp c present studi aim examin effect epa week circul sep level insulin sensit human type diabet | D003924;D050171;D007333 | T047;T046 |
34,670,010 | pre exist mycobacteri infect modul candida albican driven pyroptosi activ tuberculosi patient high risk coinfect opportunist fungal pathogen candida albican howev molecular mechan orchestr pathogenesi mycobacterium tuberculosi mtb c albican coinfect remain elus current studi util mous model demonstr mtb promot macrophag environ conduc c albican surviv mtb depend protein kinas c wnt signal axi induc express e ubiquitin ligas constitut photomorphogenesi protein cop secondari infect c albican mtb infect macrophag caus cop mediat proteasom degrad interferon regulatori factor irf cardin factor identifi arbitr inflammatori program cell death pyroptosi vivo experi mimick pre exist mtb infect demonstr inhibit pyroptosi mice result increas c albican burden aberr lung tissu architectur lead increas host mortal togeth studi reveal crucial role pyroptosi regul manifest success c albican mtb coinfect | D060085;D009169 | T007;T047 |
34,670,009 | long live organotyp slice cultur model rat basolater amygdala organotyp slice cultur otc employ laboratori sinc earli prove use studi number neural system recent work focus develop behavior stress resili induc repeat daili inject neuropeptid basolater amygdala bla resili develop week persist week unravel cellular mechan under neuropeptid induc stress resili develop vitro otc bla provid optim protocol consist yield viabl healthi otc contain bla surround tissu use interfac method prepar slice taken postnat p day rat explain key point optim tissu viabil discuss mitig avoid pitfal aris aid success implement techniqu show princip neuron bla otc week vitro equival postnat day develop network electrophysiolog similar acut slice obtain older rat p respond pharmacolog treatment compar way furthermor highlight cultur use understand molecular cellular circuit level neuropathophysiolog chang under stress disord bla otc provid long term physiolog pharmacolog result whose predict born vivo support valid bla otc model unravel bla neurocircuitri recent preliminari result also support success applic approach prepar long live otc bla neocortex mice wiley period llc basic protocol organotyp slice cultur support protocol chang medium support protocol drug incub basic protocol excis otc slice insert support protocol fixat slice | D066272;D019579 | T023;T024 |
34,670,008 | pharmacokinet safeti cenobam novel antiseizur medic healthi japanes ethnic comparison healthi non japanes cenobam xcopri ontozri novel antiseizur medic treatment focal onset seizur nonetheless limit inform pharmacokinet pks safeti efficaci cenobam asian peopl includ japanes peopl studi aim evalu pks safeti cenobam singl oral dose healthi japanes subject compar pks report non japanes subject random doubl blind placebo control singl ascend dose studi conduct four dose level mg subject random assign cenobam placebo ratio cenobam rapid absorb reach maximum plasma concentr c max h elimin mean half life h c max increas dose proport wherea area concentr time curv increas dose proport consist find non japanes subject system exposur cenobam compar japanes non japanes subject dose level evalu advers event mild sever incid show dose depend trend furthermor clinic signific issu safeti paramet includ sedat test neurolog examin columbia suicid sever rate scale interview conclus system exposur cenobam singl dose japanes subject increas dose similar pattern non japanes subject addit singl dose cenobam well toler dose rang mg healthi japanes subject | D002219;D002733 | T109 |
34,670,007 | aldehyd dehydrogenas gene recruit confer multipl abiot stress toler plant plant growth product restrict multitud abiot stress stress negat affect physiolog metabol pathway lead product mani harm substanc like ros lipid peroxid aldehyd studi conduct investig role arabidopsi aldhi gene multipl abiot stress toler transgen tobacco plant generat overexpress aldhi gene driven camv promot evalu differ abiot stress name salt drought cold oxid stress toler stress evalu base respons various growth physiolog trait stress condit transgen plant display elev aldhi transcript level compar wt plant constitut ectop express aldhi confer increas toler salt drought cold oxid stress transgen plant along improv plant growth transgen plant overexpress aldhi higher chlorophyl content photosynthesi rate prolin less accumul ros malondialdehyd compar wt contribut stress toler transgen plant result reveal aldhi posit effect co assimil rate plant abiot stress condit overal studi reveal aldhi posit regul abiot stress toler plant futur implic produc transgen cereal horticultur plant toler abiot stress | D000444;D018506 | T116;T126;T045 |
34,670,006 | genom correl trait combin antagonist select contribut counterintuit genet pattern adapt diapaus diverg rhagoleti fli adapt novel environ result unanticip genom respons select illustr multifari correl select help explain counterintuit pattern genet diverg recent deriv appl ancestr hawthorn infest host race rhagoleti pomonella diptera tephritida appl host race termin diapaus emerg adult earlier season hawthorn host race coincid earlier fruit phenolog appl host howev allel mani loci associ later emerg paradox occur higher frequenc sympatr popul appl compar hawthorn race present genom evid histor select geograph vari environment gradient across north america generat genet correl two life histori trait diapaus intens diapaus termin hawthorn host race moreov loci associ life histori trait concentr genom region high linkag disequilibrium ld genet correl antagonist contemporari select local appl host race popul favour increas initi diapaus depth earlier later diapaus termin thus paradox appl fli appear due part pleiotropi linkag allel associ later adult emerg increas initi diapaus intens latter trait strong select earlier phenolog appl result demonstr understand multivari trait combin correl natur select forc act improv predict concern adapt evolut help explain seem counterintuit pattern genet divers natur | D027825;D000074767;D000071421;D033621 | T002;T204;T078;T040;T070 |
34,670,005 | c gene regul nucleolin structur biosynthesi ribosom bovin intraspecif interspecif somat cell nuclear transfer embryo somat cell nuclear transfer scnt reprogram differenti somat cell produc individu anim thus advantag anim breed chromatin reprogram interspeci scnt iscnt provid extrem case reprogram failur use understand basic biolog mechan genom reprogram import understand possibl mechan failur zygot genom activ zga iscnt embryo order improv effici scnt embryo present studi compar develop bovin bovin b b ovin ovin scnt ovin bovin b iscnt embryo found development block exist cell stage b iscnt embryo rna sequenc q pcr analysi reveal larg ribosom subunit gene rpl small ribosom subunit gene rps express lower level b iscnt embryo nucleolin c gene regul ribosom subunit generat transcrib lower level embryon develop b iscnt embryo addit nucleolin exhibit clear circular ring structur b b cell stage embryo wherea shell like dot like b embryo furthermor overexpress c could increas blastocyst rate scnt iscnt embryo part rectifi ring like nucleolin structur express ribosom subunit relat gene upregul knockdown c increas shell like nucleolin structur b b clone embryo downregul express ribosom subunit relat gene result impli abnorm c ribosom subunit gene express would lead development block iscnt embryo zga failur overexpress c gene could part improv blastocyst develop facilit nucleolin structur bovin preimplant scnt embryo | D047108;D053652 | T039;T042;T038;T062 |
34,670,003 | exogen progesteron depend modul follicular dynam bos indicus cattl undergo repeat ovum pick session object present studi evalu role serum progesteron p follicular dynam oocyt recoveri qualiti vitro development compet consecut ovum pick opu session bos indicus dairi cow wave synchron sahiw cattl n random divid treatment n control n group cidr use sourc extern progesteron treatment group four consecut opu session hr interv conduct repeat ultrasonographi hr interv done monitor follicular dynam viabl oocyt process ivc follow ivm ivf day serum p concentr p control group record versus ngml respect p treatment group total number record follicl higher p per session recov oocyt versus p recoveri rate versus p also higher treatment group compar control similar viabl oocyt versus number grade ii oocyt per session versus higher p group taken togeth opu session serum p improv oocyt recoveri qualiti whilst affect vitro development compet recov oocyt | D006080;D011374 | T023;T121;T109;T123;T125 |
34,670,002 | unifi view vari ultrafast dynam primari process microbi rhodopsin tran cis photoisomer proton retin schiff base prsb chromophor primari step trigger various biolog function microbi rhodopsin ultrafast primari process extens studi recogn relev excit state relax dynam differ signific one rhodopsin anoth elucid origin complic ultrafast dynam primari process microbi rhodopsin studi excit state dynam proteorhodopsin dn mutant bacteriorhodopsin femtosecond time resolv absorpt ta spectroscopi wide ph rang ta data show excit state relax dynam drastic chang ph approach pk counterion residu prsb chromophor ground state result reveal vari excit state relax dynam differ rhodopsin main origin differ ground state heterogen ie protonationdeproton prsb counterion | D025604 | T116;T123 |
34,670,000 | new nonlinear optic materi n cn anion discov new function gene develop high perform materi goal pursu scientist work success obtain second order nonlinear optic nlo materi via aqueous solut method n cn nh c h h first nlo materi anion group n cn remark materi strong nlo activ nm respons kh po also possess short uv absorpt edg nm depth first principl calcul illustr well optic properti main strong interact n c atom result indic n cn anion may new nlo function gene work enrich divers nlo function gene materi | D000838 | T196 |
34,669,999 | letmd requir mitochondri structur thermogen function brown adipocyt obes metabol disord caus energi surplus pose increas concern within global popul brown adipos tissu bat dissip energi mitochondri non shiver thermogenesi thus repres power agent obes explor novel role mitochondri outer membran protein letm domain contain letmd bat generat knockout letmd ko mous model analyz bat morpholog function gene express various physiolog condit letmd ko mice born normal normal morpholog bodi weight lose multilocular brown adipocyt complet diminish mitochondri abund dna copi number crista structur thermogen gene express intrascapular bat associ elev reactiv oxid stress consequ letmd ko mice fail maintain bodi temperatur respons acut cold exposur without food becom hypotherm within h although cold expos letmd ko mice maintain bodi temperatur presenc food upregul express uncoupl protein ucp convert white beig adipocyt respond adrenerg stimul result demonstr letmd essenti mitochondri structur function thermogenesi brown adipocyt | D022722 | T040 |
34,669,998 | skill defibril practic certifi life support train healthcar provid turkey success cardiopulmonari resuscit earli defibril critic surviv hospit cardiopulmonari arrest scope multi centr studi assess skill paediatr healthcar provid hcps concern two domain recognis rhythm abnorm use defibril devic b evalu impact certifi basic life support bls advanc life support al train offer solut qualiti improv sever paediatr emerg care intens care set turkey | D016887;D004554 | T061 |
34,669,997 | ferm domain contain protein exert tumor inhibit role thyroid cancer antagon oncogen yap emerg role ferm domain contain protein frmd cancer progress reveal sever malign howev relev thyroid cancer well understood work evalu possibl role mechan frmd thyroid cancer demonstr frmd express downregul thyroid cancer analyz cancer genom atlas data remark reduct frmd express also confirm clinic specimen cell line thyroid cancer upregul frmd restrain prolifer epitheli mesenchym transit invas thyroid cancer moreov frmd overexpress signific increas apoptosi cell cycl arrest molecular research demonstr overexpress frmd increas phosphoryl level mammalian ste like protein kinas larg tumor suppressor yes associ protein yap prohibit activ yap express constitut activ yap strike revers frmd induc tumor inhibit effect thyroid cancer cell overexpress frmd weaken abil form xenograft tumor vivo nude mice overal overexpress frmd produc remark tumor inhibit effect thyroid cancer inhibit oncogen yap | D000075926;D013964 | T191;T087 |
34,669,996 | earli versus delay introduct human milk fortif enter fed preterm infant systemat review meta analysi assess effect earli versus delay introduct human milk fortif preterm infant | D020345;D008895 | T047;T031 |
34,669,995 | stress autonom nerv dysfunct monitor periop gastric cancer patient use smart devic heart rate variabl hrv sensit marker stress autonom nervous disord signific decreas cardiovascular diseas inflamm surgic injuri howev effect radic gastrectomi hrv paramet need investig | D013274 | T191 |
34,669,994 | deep learn predict epiderm growth factor receptor mutat subtyp lung adenocarcinoma studi aim explor predict abil deep learn dl common epiderm growth factor receptor egfr mutat subtyp patient lung adenocarcinoma | D000077192;D000077321;D008175 | T191;T066 |
34,669,989 | technic note surfac imag real time patient posit extern radiat therapi last year grow interest surfac imag patient posit extern radiat therapi aim studi evalu accuraci daili patient posit use azur kinect surfac imag | D011880;D061089 | T061 |
34,669,987 | adolesc experi group antenat care insight mix method studi seneg group antenat care g anc innov model antenat care deliv group women similar gestat age evid high incom countri suggest g anc particular effect women marginalis popul includ adolesc object studi examin experi senegales adolesc engag group antenat care | D017144;D011253;D011295 | T040;T033;T062;T058 |
34,669,985 | cd defici promot glutaminolysi allevi mitochondria damag vascular endotheli cell hemorrhag shock hemorrhag shock hs common clinic emerg lead million death year global cd costimulatori adhes molecul express immun cell endotheli cell ec regul metabol activ function endotheli dysfunct occur hs role cd play vascular ec metabol investig cd flfl tek cre mice adopt achiev vascular ec specif knockout cd subject hs model serum level crucial intermedi metabolit evalu liquid chromatographi mass spectrometri analysi human umbil vein ec huvec use studi effect cd hypoxia vitro seahors analysi evalu cellular glycolysi mitochondria bioenerget result show cd defici vascular ec allevi hs induc intestin damag inflammatori respons mice anim studi indic improv energi metabol cd knock ec hs evidenc enhanc glutamin glutam metabol decreas lactic acid level glut upregul mous vascular ec hs huvec hypoxia combin decreas cd moreov huvec cd knockdown exhibit reliev mitochondri damag earli apoptosi hypoxia wherea cd overexpress show opposit effect seahors analysi show downregul cd signific increas mitochondri atp product glucos uptak huvec hypoxia addit erkphd signal mediat hif glut hif asct pathway involv cd regul huvec glutaminolysi hypoxia henc cd defici promot bypass energi suppli vascular ec ischem hypox stress amelior stress mediat metabol disturb | D015687 | T043 |
34,669,984 | constitut enhanc genom integr mainten direct stress mitig character transcriptom extrem stress adapt arabidopsi halleri heavi metal rich toxic soil ordinari soil natur habitat arabidopsi halleri diploid perenni oblig outcross sister clade genet model plant arabidopsi thaliana molecular diverg under surviv sharpli contrast environ unknown compar address metal physiolog transcriptom halleri origin high heavi metal contamin soil europ pont nossa itali noss non metallifer nm soil plant noss exhibit enhanc hypertoler attenu accumul cadmium cd transcriptom cd respons decreas compar plant nm soil origin among condit independ transcriptom characterist noss high overrepres function class meiotic cell cycl compris transcript elev abund veget tissu particular argonaut ago synaptonem complex transvers filament protein encod zypab increas ago transcript level noss accompani decreas long termin repeat retrotransposon express similar noss plant high metallifer site poland germani share elev somat ago transcript level comparison plant origin nm soil respect geograph region transcript level iron regul transport irt low transcript level heavi metal atpas hma strong elev noss account alter cd handl conclud plant adapt extrem abiot stress broad enhanc function compris gene like role somat genom integr mainten accompani alter stress specif function network | D059467 | T086;T081 |
34,669,983 | human microbiom immunobul disord lichen planus sever decad signific growth incid autoimmun diseas studi indic genet factor may trigger diseas develop dysbiosi microbiom may anoth mechan involv pathogenesi autoimmun diseas role microbiom develop common skin disord psoriasi atop dermat acn rosacea increas well understood howev studi focus lichen planus rare acquir immunobul diseas mucocutan group disord link skin oral gut microbiom review provid insight current understand microbiom may contribut develop autoimmun mainten exacerb acquir immunobul lichenoid diseas mechan may implic futur prevent therapeut approach | D064307 | T032;T001;T028 |
34,669,982 | long term chang temper marin fish assemblag driven small subset speci speci composit plant anim assemblag across globe chang substanti past centuri dynam individu speci caus chang classifi speci seven uniqu categori tempor dynam base order sequenc presenc absenc speci contribut assemblag time seri appli framework speci trajectori compris assemblag temper marin fish survey annual year although assemblag diverg speci composit baselin year composit chang larg driven speci trajectori quantifi reorgan assemblag base speci share tempor dynam facilit task monitor restor biodivers suggest way framework could provid inform measur composit chang well leverag futur research pattern process ecolog system | D044822;D005399 | T080;T013 |
34,669,981 | alemtuzumab clearanc lymphocyt count cell chimer hematopoiet stem cell transplant sickl cell diseas alemtuzumab monoclon antibodi target cell surfac antigen cd lymphocyt although use treatment hematolog malign chronic lymphocyt leukemia incorpor mani hematopoiet stem cell transplant hsct condit regimen studi evalu pharmacolog alemtuzumab adult patient sickl cell diseas scd therefor examin pharmacokinet pk pharmacodynam pd alemtuzumab adult scd receiv match relat donor hsct determin clearanc alemtuzumab affect transplant outcom | D000755;D018380 | T047;T061 |
34,669,979 | current pharmacotherapi manag children adult pericard prospectus improv outcom pericard common inflammatori pericardi diseas children adult sinc european societi cardiolog guidelin diagnosi manag pericardi diseas publish signific updat manag pharmacotherapi histor reserv idiopath pericard ip howev increas use pharmacotherapi anti inflammatori therapi colchicin immunotherapi caus pericard post cardiac injuri syndrom pcis nevertheless qualiti data vari depend pcis idiopath etiolog well adult pediatr popul high dose anti inflammatori therapi use manag symptom associ either etiolog pericard adult children amelior inflammatori diseas process choic anti inflammatori guid drug drugdiseas interact cost toler patient age taper accord sever week month colchicin ad adjuv therapi anti inflammatori therapi adult children ip shown lower risk recurr reduc pericard symptom improv morbid colchicin also reason add adult children pericard secondari pcis system glucocorticoid increas risk recurr adult children ip reserv second line treatment acut recurr ip general avoid pcis immunotherapi regard third line recurr ip adult children limit evid exist support use patient pericard pcis pharmacovigil strategi c reactiv protein advers drug event monitor also import toward balanc efficaci safeti various strategi use manag pericard adult children | D010493 | T047 |
34,669,978 | acquir epidermodysplasia verruciformi aev three children cardiac transplant case seri review literatur acquir epidermodysplasia verruciformi aev describ epidermodysplasia verruciformi develop immunocompromis host limit inform literatur regard aev pediatr popul patient report patient describ hiv two report case children develop aev post transplant case seri describ three pediatr patient develop aev immunosuppress therapi follow cardiac transplant review risk factor treatment option prognosi aev pediatr popul | D004819;D016027 | T191;T061 |
34,669,977 | stabil glutathion ad supplement parenter nutrit prematur newborn week gestat receiv parenter nutrit pn inher contamin peroxid oxid stress induc pn associ bronchopulmonari dysplasia main patholog complic infant weak antioxid capac detoxifi peroxid glutathion defici anim glutathion supplement pn prevent oxid stress alveolar loss main characterist bronchopulmonari dysplasia two form oxid glutathion gssg reduc glutathion gsh gssg use better stabil howev loss gssg pn observ potenti high therapeut benefit gssg supplement health prematur infant make studi stabil high import | D001997 | T047 |
34,669,976 | advanc treatment transthyretin cardiac amyloidosi current emerg therapi transthyretin cardiac amyloidosi attr ca recogn underdiagnos undertr caus heart failur often unrecogn multiorgan involv guidelin develop establish nonbiopsi criteria diagnosi attr ca led increas rate diagnosi henc patient refer therapi attr protein misfold disord ttr tetram disassoci monom form insolubl amyloid deposit organ includ heart attr ca due autosom domin transmit gene mutat due misfold wild type ttr prior fda approv pharmacolog treatment attr ca understand attr ca pathogenesi enabl develop target strategi novel diseas modifi therapi current emerg therapi attr ca includ ttr gene silenc sirna aso crisprca ttr tetram stabil ttr amyloid fibril degrad review focus pathophysiolog attr ca diagnost criteria address current emerg treatment divers disord | D028227;D006331 | T047 |
34,669,975 | valid determinist linear boltzmann transport equat solver rapid ct dose comput use physic dose measur pediatr phantom risk induc cancer patient undergo ct examin motiv effort ct dose estim monitor reduct especi among pediatr popul method investig studi acuro ctd varian medic system palo alto ca determinist linear boltzmann transport equat lbte solver aim generat rapid reliabl dose map ct exam appli organ contour organ dose also obtain thus patient specif organ dose estim provid studi experiment valid acuro measur perform clinic ct system use rang physic pediatr anthropomorph phantom acquisit protocol | D011874;D014057 | T074;T059;T073;T060 |
34,669,973 | indirect impact sar cov pandem pregnanc childbirth outcom nine month long experi univers center lombardi determin impact perinat health chang social polici obstetr care implement curb sar cov transmiss howev robust data topic lack sinc studi examin first month outbreak | D000086382;D011251;D047928 | T046;T047;T067 |
34,669,971 | interleukin e induc nitric oxid synthas arginas new biomark identif neutrophil dermatos neutrophil dermatos nd heterogen group diseas often relat similar histolog appear | D003872;D011565 | T047 |
34,669,967 | scope studi definit instrument measur vulner older adult import foster social particip health equiti especi older adult situat vulner despit grow interest vulner consensus regard defin measur concept paper provid inventori synthesi definit instrument measur vulner older adult | D000375;D000069576;D035862 | T040;T033;T080;T098 |
34,669,966 | surviv salmonella enterica militari low moistur food product long term storag c salmonella enterica increas implic foodborn outbreak involv low moistur food lmf recent decad studi aim investig potenti persist enterica rang lmf storag three temperatur lmf product boil bag egg freez dri product chocol protein drink cran raspberri first strike bar mocha dessert bar peanut butter inocul five strain cocktail enterica store c month salmonella popul remain log cfug product store c log cfug product store c exclud cran raspberri first strike bar storag c result salmonella popul log cfug boil bag egg month demonstr surviv month less five product addit mocha bar product temperatur profil studi identifi rapid cool bar temperatur reach would measur impact salmonella popul result indic abil salmonella surviv varieti lmf categori food even advers storag condit identifi food matrix may affect salmonella surviv data indic import establish food process procedur adequ mitig presenc salmonella throughout food process system also increas comprehens understand salmonella surviv mechan | D008889;D019779 | T097;T007 |
34,669,964 | character heat tobacco product use among adult cigarett smoker nicotin vape product user itc four countri smoke vape survey heat tobacco product htp diversifi global tobacco market user characterist remain understudi studi evalu sociodemograph characterist nicotin relat percept behavior current htp user within sampl adult year nicotin user across four countri | D066300;D062789;D000072137 | T055;T131;T073;T109 |
34,669,962 | ubibrows comprehens resourc proteom wide known predict ubiquitin ligasedeubiquitinas substrat interact eukaryot speci import post translat modif ubiquitin mediat protein degrad eukaryot degre protein ubiquitin tight determin delic balanc specif ubiquitin ligas e mediat ubiquitin deubiquitinas mediat deubiquitin develop ubibrows integr databas predict human proteom wide e substrat interact meet urgent requir proteom wide edeubiquitinas substrat interact esisdsi multipl organ updat ubibrows version http ubibrowserncpsborgcn use improv protocol collect known esisdsi manual curat predict million high confid esisdsi organ fold increas total data volum addit made sever new featur updat version allow explor protein upstream e ligas deubiquitinas simultan ii signific increas speci coverag iii present uniform confid score system rank predict esisdsi facilit usag ubibrows also redesign web interfac explor known predict esisdsi ad function brows download applic program interfac believ ubibrows discoveri tool contribut studi protein ubiquitin develop drug target complex diseas | D030541;D012984 | T170;T073;T090 |
34,669,959 | pasta structur affect mastic bolus properti postprandi glucos insulin metabol healthi adult structur protein starch interact pasta product respons lower postprandi glycem respons compar cereal food | D005947;D061385 | T121;T109;T123 |
34,669,958 | broaden reach investig potenti prime editor fulli viral gene delet adenovir vector deliveri prime edit recent precis genom edit modal whose versatil offer prospect wide rang applic includ develop target genet therapi yet outstand bottleneck optim use concern difficulti deliv larg prime edit complex cell demonstr packag prime edit construct adenovir capsid overcom constrain result robust genom edit transform non transform human cell effici use cell cycl independ deliveri platform found direct correl prime edit activ cellular replic disclos proport accur prime edit event unwant byproduct influenc target cell context henc adenovector particl permit efficaci deliveri test prime edit reagent human cell independ transform replic status herein integr gene deliveri gene edit technolog expect aid investig potenti limit prime edit numer experiment set eventu ex vivo vivo therapeut context | D018014 | T062;T063 |
34,669,957 | preclin pharmacolog toxicolog evalu anti cd monoclon antibodi produc perfus ferment process anti cluster differenti cd monoclon antibodi mab employ treatment chronic lymphoblast leukemia multipl sclerosi previous develop perfus process produc biosimilar mab name mab th seri qualiti assess conduct field structur identif puriti analysi activ measur qualiti research report laid emphasi preclin pharmacolog toxicolog evalu mab th character biolog pharmacolog toxicolog properti comparison origin drug alemtuzumab bind activ immun depend toxic vitro activ evalu sever immunodefici mice transplant human leukemia cell line also use vivo pharmacolog model week repeat dose studi cynomolgus monkey conduct evalu safeti differ result demonstr mab th anti cd antibodi generat perfus process high similar vitro vivo activ compar alemtuzumab relev preclin model result support biosimilar candid clinic evalu | D000911;D061067 | T129;T116 |
34,669,956 | random trial nicotin versus nicotin e cigarett among african american smoker chang smoke tobacco biomark object clinic trial compar effect e cigarett without nicotin pattern combust cigarett use biomark exposur tobacco toxic among african american smoker | D000073865;D066300;D062789 | T131;T109;T073;T055 |
34,669,955 | use facebook instagram twitter recruit healthi particip nutrit physic activ obes relat studi systemat review limit systemat review explor use social media recruit particip specif nutrit physic activ obes relat studi | D018579;D061108 | T058;T080;T062;T170 |
34,669,948 | constraint error rate reveal comput studi gu tautomer translat translat gu mismatch codon anticodon decod error hotspot like due transit gu wobbl wb watson crick wc geometri govern ketoenol tautomer wb wc reaction yet effect ribosom wb wc reaction implic decod mechan remain unclear employ quantum mechanicalmolecular mechan umbrella sampl simul use model ribosom decod site site determin wb wc reaction endoerg open weak exoerg close site state extend classic induc fit model initi select incorpor wb wc reaction paramet open close state predict paramet non equilibrium exoerg wb wc reaction kinet limit decod rate model explain earli observ wc geometri gu equilibrium structur studi reveal discrimin capac work ribosom oper non equilibrium condit equilibr exoerg wb wc reaction counteract equilibr open close transit site constrain decod accuraci potenti explain persist gu error hotspot result unifi structur mechanist view codon anticodon decod general induc fit model flexibl substrat | D020137;D020029;D056004 | T049;T044;T066 |
34,669,947 | balanc act transcript regul respons regul titrat transcript factor activ decoy dna bind site studi transcript regul often focus bind transcript factor tfs small number promot interest often assum tfs great excess bind site tfbss competit tfs dna site seldom consid increas evid tfbss exceed abund mani tfs signific variat tf tfbs number occur growth interplay tf tfbss ignor use addit decoy dna site quantit analyz relat abund tf tfbss impact steadi state level onset time gene express auto activ escherichia coli phob respons regul show increas number decoy site progress delay transcript activ lower promot activ perturb transcript regul addit tfbss requir extrem number decoy suggest phob approxim capac dna site addit decoy also convert grade respons bi modal respons develop bind competit model captur major featur experiment observ provid quantit framework assess variat tfs tfbss influenc transcript respons | D015964;D059372 | T086;T045 |
34,669,946 | webtwa resourc diseas candid suscept gene identifi transcriptom wide associ studi develop transcriptom wide associ studi twas enabl research better identifi interpret causal gene mani diseas howev current resourc provid comprehens list gene diseas associ discov twas publish gwas summari statist twas analys also difficult conduct due complex twas softwar pipelin address issu introduc new resourc call webtwa integr databas comprehens diseas gwas dataset current avail credibl set potenti causal gene identifi multipl twas softwar packag specif total gene diseas associ wide rang human diseas priorit high qualiti download european gwas summari statist associ calcul seven differ statist model base three popular repres twas softwar packag user explor associ gene diseas level easili search relat studi diseas use mesh diseas tree sinc effect diseas high tissu specif webtwa appli tissu specif enrich analysi identifi signific tissu user friend web server also avail run custom twas analys user provid gwas summari statist data webtwa freeli avail http wwwwebtwasnet | D030541;D020022 | T032;T170 |
34,669,944 | matern selenium defici suppress prolifer induc autophagi dysfunct apoptosi placenta mice selenium defici thought associ occurr gestat complic howev under mechan selenium defici impair placent function remain unclear studi femal mice separ supplement se defici mgkg se control diet mgkg se week mate throughout gestat matern liver placenta collect embryon day analyz se content oxid stress status prolifer capabl autophagi apoptosi placenta determin found matern selenium defici decreas placent se concentr antioxid selenoprotein express concentr catalas glutathion selenium defici placenta reduc along increas hydrogen peroxid ho content selenium defici inhibit express prolifer cell nuclear antigen autophagosom autophagolysosom upregul autophagi relat protein microtubul associ protein light chain alpha ii lcb beclin pten induc putat kinas pink parkin found selenium defici trophoblast autophag substrat psequestosom surpris increas indic autophagi flux dysfunct selenium defici increas express b cell leukemialymphoma associ x protein bax cleav caspas decreas b cell leukemialymphoma bcl level moreov typic apoptot ultrastructur apoptosi posit cell observ selenium defici placenta result suggest matern selenium defici impair placent prolifer induc autophagi dysfunct apoptosi via increas oxid stress aktmechanist target rapamycin mtor pathway involv process studi reveal novel mechan matern selenium defici caus impair placenta | D017209;D001343;D049109 | T043;T116;T123 |
34,669,940 | caus consequ polycyst ovari syndrom insight mendelian random although polycyst ovari syndrom pcos common endocrinopathi affect women reproduct age risk factor may caus syndrom poor understood base epidemiolog studi pcos thought caus sever advers outcom cardiovascular diseas howev common presenc comorbid obes may respons associ rather pcos overcom limit observ studi investig employ mendelian random mr use genet variant interrog causal exposur outcom | D020022 | T032 |
34,669,937 | flake densiti starch retrograd influenc situ rumin degrad characterist steam flake corn predict starch digest energet effici five rumin cannul steer bodi weight kg use two experi evalu effect flake densiti starch retrograd situ rumin degrad steam flake corn experi sift flake flake densiti gl enzymat starch avail respect evalu random complet block design experi experi experiment design random complet block design factori arrang treatment three steam flake corn fraction correspond differ particl size use flake fine sift mm sift fine mm particl size fraction store either c c starch avail averag across particl size respect heat seal foil bag sampl rumin incub h degrad data model obtain rate extent degrad passag rate set per hour experi rate degrad decreas linear p situ rumin dri matter dm degrad decreas linear p flake densiti increas gl experi storag steam flake corn sampl c decreas p rate degrad across particl size store sampl c decreas p situ rumin dm degrad flake fine sift flake sift fine respect use data experi enzymat starch avail sift flake posit correl r p situ rumin dm degrad result demonstr decreas starch avail result either starch retrograd increas flake densiti associ decreas rumin digest decreas starch avail situ rumin degrad may indic increas flake densiti starch retrograd could potenti alter site digest cattl use predict equat decreas rumin starch digest steam flake corn caus increas flake densiti increas starch retrograd could increas energet effici depend rate passag small intestin starch digest maintain | D013213;D003313 | T121;T002;T109;T123;T168 |
34,669,936 | map qualiti basic comprehens emerg obstetr care servic haiti investig geograph inequ chang qualiti emerg obstetr care servic avail haiti time | D004632;D008427 | T058;T093;T061 |
34,669,935 | interact rs polymorph mtnrb lifestyl intervent matern neonat outcom secondari analys dali lifestyl random control trial interact polymorph melatonin receptor b mtnrb gene lifestyl intervent gestat diabet describ whether specif physic activ healthi eat intervent unknown | D000072001;D008019;D011110 | T047;T045;T055;T054;T061;T033 |
34,669,933 | risk later diagnosi inflammatori bowel diseas patient dermatolog disord associ inflammatori bowel diseas dermatolog condit erythema nodosum en pyoderma gangrenosum sweet syndrom aphthous stomat occur inflammatori bowel diseas ibd consid dermatolog extraintestin manifest eim rare may preced ibd common condit psoriasi also associ ibd studi examin risk subsequ ibd diagnosi patient present eim | D003093;D003424;D004893;D015212;D011565 | T047 |
34,669,931 | identif enzym pseudogluconobact saccharoketogen produc glucar acid glucos us depart energi list glucar acid one top bio base chemic potenti biopolym build block studi show pseudogluconobact saccharoketogen strain produc glucar acid glucos although low yield generat byproduct keto glucon acid larg quantiti improv glucar acid yield generat rh p saccharoketogen ifo mutant produc glucar acid glucon acid glucos mol yield respect furthermor key enzym involv glucar acid product alcohol dehydrogenas ps adh aldehyd dehydrogenas ps aldh glucon dehydrogenas ps gadh purifi role glucar acid synthesi evalu ps adh ps aldh catalyz glucar acid product mediat glucon acid glucuron acid pathway contrast ps gadh inhibit glucar acid product promot format keto glucon acid glucos | D001419 | T007 |
34,669,929 | genet predict lifelong circul oh level associ serum calcium level kidney stone risk assess whether lifelong higher circul hydroxyvitamin oh level increas serum calcium level kidney stone diseas ksd risk | D020022 | T032 |
34,669,928 | student senior isol prevent partnership canada wide programm mitig social exclus covid pandem amidst pandem canada taken critic step curb transmiss novel coronavirus diseas covid key intervent physic distanc although physic distanc may protect older adult risk group covid research suggest quarantin isol may worsen mental health among older adult social exclus social safeti net social determin health sdoh may uniqu affect covid physic distanc measur health promot programm design reduc social exclus enhanc social safeti net one way mitig potenti mental health implic pandem student senior isol prevent partnership ssipp student led communiti health promot initi scale nation wide effort improv social connect among older adult initi began person visit transform tele intervent guid health promot principl due covid ssipp continu target sdoh social exclus social safeti net pair student volunt older adult engag week phone video base interact inform communiti partnership model best et al ssipp built three orient empower behaviour organ achiev cross disciplinari collabor articl review import adapt health promot programm ssipp pandem place emphasi lesson learn futur step | D000086382;D058873 | T047;T067 |
34,669,925 | assess microbiolog qualiti safeti unpasteur milk chees sale england chees made unpasteur milk associ outbreak ill howev limit data preval shiga toxin produc escherichia coli stec product lack clariti signific e coli general indic hygien raw milk chees aim studi provid data address issu well assess overal microbiolog qualiti raw milk chees avail consum england total sampl chees collect retail cater premis manufactur throughout england major made use cow milk made sheep milk goat milk sampl differ countri origin major origin either unit kingdom franc interpret european union microbiolog criteria unit kingdom guidanc consid satisfactori microbiolog qualiti borderlin unsatisfactori four sampl potenti injuri health due isol stec one cfug coagulas posit staphylococci two cfug listeria monocytogen fourth sampl indic e coli listeria speci detect frequent soft compar hard chees higher level indic e coli signific associ greater likelihood detect shiga toxin gene stx andor stx | D002611;D054323 | T007;T168 |
34,669,923 | control microbi composit ferment ishizuchi kurocha ishizuchi kurocha popular postfer tea japan perform domest natur ferment reli microorgan deriv tea leav environ manufactur ishizuchi kurocha undergo aerob ferment fungi first second ferment anaerob ferment lactic acid bacteria natur ferment process aspergillus niger produc mycotoxin includ natur ferment research aim build novel ferment method ishizuchi kurocha ad industri koji fungi product laboratori cultiv lactobacillus plantarum lactiplantibacillus plantarum artifici thus safeti qualiti tea product could control simpli found artifici ferment ishizuchi kurocha could get high lactic acid product within day final product consist genus aspergillus genus lactobacillus harm aspergillus niger found howev artifici ferment method also decreas content polyphenol compar commerci tea | D001230 | T004 |
34,669,917 | longitudin studi effect previous stillbirth abort subsequ pregnanc infant studi conduct assess effect stillbirth abort health subsequ newborn | D000028;D000022 | T047;T046;T093;T061;T081;T033 |
34,669,915 | molecular investig subgenus artemisia less genus artemisia l asteracea turkey genus artemisia l famili asteracea systemat complex aim studi evalu taxonom posit taxa subgenus artemisia belong genus artemisia turkey use molecular techniqu molecular studi individu belong speci subgenus artemisia examin analys perform combin dataset use maximum parsimoni maximum likelihood bayesian infer molecular paramet obtain co evalu sequenc psba trnh et region examin individu use phylogenet tree draw accord result studi two molecular group form base dna sequenc similar speci obvious morpholog charact correspond two molecular group also agreement two molecular group two morpholog group form accord hairi condit receptacl speci due lack molecular signific receptacl without hair divid subgenus artemisia speci new subgenera section consid appropri likewis found without hair corolla lobe central hermaphrodit disc flower molecular signific found gene flow hybrid speci subgenus artemisia speci found complet speciat studi import first molecular base studi relat belong subgenus artemisia speci grow natur turkey addit new haplotyp relat popul turkey belong subgenus artemisia taxa report us first time ad genbank databas | D019306 | T002 |
34,669,914 | eugenol liposom base nano carrier reduc anxieti inhibit glyoxylas express mice common form psycho social dysfunct anxieti depress relat close without age bar present combin state sad confus stress fear etc glyoxalas system contain enzym name glyoxalas glo metabol pathway detoxifi alpha oxo aldehyd particular methylglyox mg methylglyox main made breakdown glycolyt intermedi glyceraldehyd phosphat dihydroxyaceton phosphat glyoxylas express also relat anxieti behavior casual role glo anxieti behavior use viral vector express anterior cingul cortex found found local glo express increas anxieti behavior present studi deal molecular mechan protect activ eugenol anxiolyt disord pre clinic anim studi perform balbc mice anim given stress convent restrain model mrna express glo analyz real time rt pcr moreov glo protein express also examin immunohistochemistri whole brain mean densiti calcul mrna protein express found increas anim given anxieti compar normal control wherea express decreas anim treat eugenol liposom base nanocarri dose depend manner howev result better anim treat nanocarri compar compound alon conclud eugenol liposom base nanocarri exert anxiolyt activ regul glo protein express mice | D005054 | T121;T109 |
34,669,913 | spectral analysi antibacteri activ bioactiv principl sargassum tenerrimum j agardh collect red sea jazan kingdom saudi arabia seawe major marin resourc explor develop novel pharmaceut molecul present studi show presenc uniqu bioactiv compon petroleum ether extract pee methanol extract sargassum tenerrimum gas chromatographi mass spectrometri analysi suggest pee tenerrimum contain antibacteri biomolecul hexadecano acid methyl ester pentatriaconten dasycarpidan methanol acet ester howev tenerrimum exhibit better antibacteri effect pee due presenc bioactiv compound benzenedicarboxyl acid diisooctyl ester tetratetracontan docosen benzenediol benzoic acid thus promis antibacteri molecul isol tenerrimum better therapeut use | D044647 | T204 |
34,669,912 | monitor insecticid resist cotton jassid amrasca biguttutla biguttutla laboratori condit develop insecticid resist main hing manag techniqu control jassid amrasca biguttutla biguttutla five insecticid appli field collect laboratori rare jassid popul year profil resist level field popul jassid leaf dip method low resist level found jassid confidor wherea high level resist observ pyriproxyfen test insecticid gradual resist observ diafenthiuron conclud manag jassid repetit insecticid avoid use confidor may reduc overcom resist jassid | D006430;D007306 | T131;T204 |
34,669,911 | inhibitori effect cannabi sativa l morus nigra l lipid peroxid goat liver brain homogen present studi aim evalu antioxid potenti inhibitori effect ofcannabi sativa morus nigra lipid peroxid goat brain liver homogen format free radic high reactiv oxygen speci ros reactiv nitrogen speci rns normal metabol process cellular signal counter antigen howev may caus serious damag produc amplifi toll addit metabol disord also serv sourc reactiv speci although issu address supplement phytochem studi two plant speci evalu biolog potenti employ spectrum antioxid assay antioxid activ perform lipid peroxid assay water extract prepar leav cannabi sativa morus nigra show signific p inhibit compar control ie gml iron induc lipid peroxid goat brain homogen inhibit gml nitroprussid induc lipid peroxid brain iron nitroprussid induc lipid peroxid also signific inhibit leaf extract cannabi sativa morus nigra liver homogen gml iron induc gml nitroprussid induc respect extract cannabi sativa extract show promis activ dpph radic morus nigra show moder activ result suggest differ access ofcannabi sativa morus nigra potenti sourc antioxid therapeut effect diseas induc oxid stress henc use novel drug discoveri develop | D002188;D031625 | T167;T121;T002;T109 |
34,669,909 | act play signifi applic dramat therapeut toy perform nurs theoret reflect reflect possibl contribut act play signifi use dramat therapeut toy perform nurs | D001007;D005190 | T184;T079;T099;T041;T048;T054;T062 |
34,669,908 | human childbirth valu health profession daili obstetr care understand health profession valu process think feel obstetr care base experienc need care process | D036861;D036801 | T040;T061 |
34,669,907 | method measur venous peripher insert central cathet newborn analyz result insert procedur peripher insert central cathet newborn use two measur method | D002405;D002406;D062905 | T058;T074;T061 |
34,669,906 | profession safeti daili life primari health care ground theori understand profession safeti daili life primari health care | D006282;D011320 | T097;T058 |
34,669,905 | adher antiretrovir therapi adult live hivaid cross section studi verifi associ adher antiretrovir treatment adult hivaid sociodemograph factor social clinic support | D015658;D055118 | T033;T047;T081;T055 |
34,669,904 | death die newborn children relationship nurs famili accord travelbe identifi nurs staff percept relationship famili newborn children process death die | D003142;D004644 | T097;T170;T041;T054;T080 |
34,669,903 | clinic progress covid coinfect peopl live human immunodefici virus scope review map product scientif knowledg clinic progress covid coinfect peopl live human immunodefici virus hiv | D000086382;D060085;D015658 | T047;T067 |
34,669,902 | methodolog path reach degre satur qualit research ground theori achiev degre satur studi appli ground theori | D066296 | T170 |
34,669,901 | inform communic technolog interfac nurs work process unveil mean nurs attribut inform communic technolog nurs work process | D003142;D009042 | T097;T170;T041;T054;T078;T080 |
34,669,900 | clinic simul nurs fundament teach method quasi experiment studi evalu student knowledg gain implement clinic simul nurs fundament disciplin | D004508;D013338 | T097;T065 |
34,669,899 | impair knowledg individu heart failur middl rang nurs theori develop middl rang nurs theori impair knowledg individu heart failur | D006333;D009742 | T047;T078;T046 |
34,669,898 | care relat peripher intraven catheter pediatr perform nurs technician evalu care practic adopt nurs technician peripher intraven catheter perform hospit children | D002406;D010372 | T058;T091;T061 |
34,669,897 | health educ hospit patient nurs care conceptu analysi defin concept health educ hospit patient | D009732 | T058 |
34,669,896 | covid nurs labor market lesson learn analog histor event reflect impact brazil respons covid pandem demand nurs labor market light recoveri experi usa world war ii | D000086382;D058873 | T047;T067 |
34,669,894 | softwar assist imag analysi identif quantif hepat sinusoid dilat centrilobular fibrosi heart dysfunct liver diseas often coexist system disord caus right ventricular failur may precipit hepat congest fibrosi digit imag technolog introduc patholog diagnosi allow object quantit assess quantif fibrous tissu liver biopsi section extrem import classif diagnosi grade chronic liver diseas | D007091;D012984 | T170;T066;T073;T090 |
34,669,893 | role fistuloclysi treatment patient enteroatmospher fistula enterocutan fistula repres connect gastrointestin tract adjac tissu among subdivis enteroatmospher fistula origin gastrointestin tract connect extern environ open wound abdomen due high output enterocutan fistula loss fluid electrolyt miner protein lead complic sepsi malnutrit electrolyt derang parenter nutrit secondari risk fistuloclysi consist infus enter feed also chyme distal fistula repres altern manag patient definit surgic approach | D007412;D018805 | T190;T047;T046 |
34,669,892 | femor hernia uncommon associ potenti sever complic although laparoscop access becom prefer treatment femor hernia studi import subject | D006550;D006552;D010535 | T047;T190;T020;T061;T060 |
34,669,891 | bodi mass index obes surgeri mortal score import periop complic laparoscop sleev gastrectomi discharg morbid obes surgeri relat complic increas time | D010535;D009767 | T061;T047;T060 |
34,669,890 | enterotyp obes modifi bariatr surgeri use probiot supplement food habit studi suggest bariatr surgeri use probiot supplement dietari pattern chang enterotyp well entir microbi popul | D050110;D000069196;D019936 | T007;T001;T061 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.